Evaxion Biotech A/S

EVAX

NASDAQHealth Care

Income Statement

Total Revenue$3.73M

Gross Profit$3.73M

Operating Income$-46.09M

EBITDA$-71.93M

EBIT$-38.19M

Pre-tax Income$-8.62M

Net Income$-45.09M

Net Cash$232.34M

Cash Equivalent$6.88M

Total Debt$10.49M

Net Debt$-221.85M

Book Value$-3.96M

Net Cash Per Share0.47

Book Value Per Share-0.10

Return on Equity (ROE)-279.04%

Return on Assets (ROA)-84.64%

Return on Invested Capital (ROI)-124.85%

Net Profit Margin-316.00%

Current Ratio2.01

Quick Ratio1.78

Long-Term Debt / Equity0.95